Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome

Publisher： Karger

E-ISSN： 1423-0399|86|1|68-72

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.86, Iss.1, 2010-07, pp. : 68-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 128-134

Bentham Science Publishers

Access to resources Recommend Favorite

Current Information on Sacral Neuromodulation and Botulinum Toxin Treatment for Refractory Idiopathic Overactive Bladder Syndrome: A Review

By  

Urologia Internationalis, Vol. 84, Iss. 3, 2010-04 ,pp. : 245-253

Karger

Access to resources Recommend Favorite

Botulinum toxin: historical perspective and treatment of neurogenic and idiopathic overactive bladder

By Mulligan Daniel   Bologna Raymond  

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 165-175

Future Medicine

Access to resources Recommend Favorite

Botulinum Toxin-A Injections for Idiopathic Overactive Bladder: A Systematic Review and Meta-Analysis

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-08 ,pp. : 429-438

Karger

Access to resources Recommend Favorite

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence

By Rogers Rebecca G.   Bachmann Gloria   Scarpero Harriette   Jumadilova Zhanna   Sun Franklin   Morrow Jon D.   Guan Zhonghong   Bavendam Tamara  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2159-2165

Informa Healthcare

Access to resources Recommend Favorite